FORT Trial TT

Safety and Feasibility of a Shorter Course of Radiation Therapy for Men with Low or Intermediate Risk Prostate Cancer (FORT)

Details
In this trial, Weill Cornell Medicine is investigating the safety and feasibility of a shorter course of radiation therapy for men with low or intermediate risk prostate cancer. The trial compares the effectiveness of MRI-guided adaptive radiotherapy delivered in either two or five treatment days. The goal of the trial is to benefit future prostate cancer patients by increasing convenience, reduci...